AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 79 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,473,836 | +24.6% | 16,205,119 | 0.0% | 31.57% | +63.7% |
| Q2 2023 | $14,827,684 | +63.3% | 16,205,119 | 0.0% | 19.29% | +60.8% |
| Q1 2023 | $9,081,349 | +4.3% | 16,205,119 | +7.4% | 12.00% | +19.8% |
| Q4 2022 | $8,706,999 | +491.9% | 15,090,119 | +224.3% | 10.02% | +607.3% |
| Q3 2022 | $1,471,000 | -10.4% | 4,652,561 | 0.0% | 1.42% | -53.5% |
| Q2 2022 | $1,642,000 | -50.8% | 4,652,561 | 0.0% | 3.05% | -46.1% |
| Q1 2022 | $3,340,000 | -68.2% | 4,652,561 | 0.0% | 5.66% | -47.1% |
| Q4 2021 | $10,515,000 | -21.5% | 4,652,561 | 0.0% | 10.70% | +16.6% |
| Q3 2021 | $13,399,000 | -24.0% | 4,652,561 | 0.0% | 9.17% | -4.2% |
| Q2 2021 | $17,633,000 | +12.0% | 4,652,561 | 0.0% | 9.57% | +37.4% |
| Q1 2021 | $15,749,000 | +20.9% | 4,652,561 | 0.0% | 6.97% | +35.8% |
| Q4 2020 | $13,027,000 | – | 4,652,561 | – | 5.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $10,515,000 | 10.70% |
| Orchard Capital Management, LLC | 1,593,531 | $3,601,000 | 1.06% |
| Nantahala Capital Management | 4,918,565 | $11,116,000 | 0.39% |
| Ardent Capital Management, Inc. | 168,811 | $382,000 | 0.25% |
| Birchview Capital, LP | 100,000 | $226,000 | 0.15% |
| Nantahala Capital Management | 1,000,000 | $2,260,000 | 0.08% |
| PDT Partners, LLC | 433,400 | $979,000 | 0.08% |
| Woodline Partners LP | 2,231,966 | $5,044,000 | 0.07% |
| Virtus ETF Advisers LLC | 69,015 | $156,000 | 0.06% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 2,737,900 | $6,188,000 | 0.04% |